KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Revenue (2016 - 2026)

Bristol Myers Squibb has reported Revenue over the past 18 years, most recently at $11.5 billion for Q1 2026.

  • Quarterly Revenue rose 2.57% to $11.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $48.5 billion through Mar 2026, up 1.78% year-over-year, with the annual reading at $48.2 billion for FY2025, 0.22% changed from the prior year.
  • Revenue was $11.5 billion for Q1 2026 at Bristol Myers Squibb, down from $12.5 billion in the prior quarter.
  • Over five years, Revenue peaked at $12.5 billion in Q4 2025 and troughed at $11.0 billion in Q3 2023.
  • The 5-year median for Revenue is $11.6 billion (2022), against an average of $11.7 billion.
  • Year-over-year, Revenue increased 8.69% in 2024 and then fell 5.6% in 2025.
  • A 5-year view of Revenue shows it stood at $11.4 billion in 2022, then increased by 0.62% to $11.5 billion in 2023, then increased by 7.54% to $12.3 billion in 2024, then increased by 1.3% to $12.5 billion in 2025, then dropped by 8.1% to $11.5 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Revenue are $11.5 billion (Q1 2026), $12.5 billion (Q4 2025), and $12.2 billion (Q3 2025).